Quick Takeaways
- Shay Capital LLC filed SCHEDULE 13G for OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (OKUR).
- Disclosed ownership: 6.3%.
- Date of event: 15 May 2025.
Quoteable Key Fact
"Shay Capital LLC disclosed 6.3% ownership in OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (OKUR) on 15 May 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Shay Capital LLC | 6.3% | 810,214 | 810,214 | 0 | Elan Foxman | Chief Financial Officer | |
| Shay Capital Holdings LLC | 6.3% | 810,214 | 810,214 | 0 | Elan Foxman | Chief Financial Officer |